BRISTOL-MYERS SQUIBB COMPANY Sale Leaseback Transaction, Deferred Gain, Net
BRISTOL-MYERS SQUIBB COMPANY (BMY) had Sale Leaseback Transaction, Deferred Gain, Net of $31.00 million as of 2015-09-30, per its 10-Q filed 2015-10-27.
Discontinued › Notes › Leases
us-gaap:SaleLeasebackTransactionDeferredGainNet · last filed 2015-10-27
- 2015-09-30: Sale Leaseback Transaction, Deferred Gain, Net $31.00M.
- 2015-06-30: Sale Leaseback Transaction, Deferred Gain, Net $35.00M.
- 2015-03-31: Sale Leaseback Transaction, Deferred Gain, Net $39.00M.
- 2014-12-31: Sale Leaseback Transaction, Deferred Gain, Net $45.00M.
| Period end | Sale Leaseback Transaction, Deferred Gain, Net |
|---|---|
| 2015-09-30 | $31.00M 10-Q · filed 2015-10-27 |
| 2015-06-30 | $35.00M 10-Q · filed 2015-07-23 |
| 2015-03-31 | $39.00M 10-Q · filed 2015-04-28 |
| 2014-12-31 | $45.00M 10-Q · filed 2015-10-27 |
| 2014-09-30 | $50.00M 10-Q · filed 2014-10-24 |
| 2014-06-30 | $57.00M 10-Q · filed 2014-07-24 |
| 2014-03-31 | $64.00M 10-Q · filed 2014-04-29 |
| 2013-12-31 | $71.00M 10-K · filed 2015-02-13 |
| 2013-09-30 | $78.00M 10-Q · filed 2013-10-23 |
| 2013-06-30 | $85.00M 10-Q · filed 2013-07-25 |
| 2013-03-31 | $91.00M 10-Q · filed 2013-04-25 |
| 2012-12-31 | $99.00M 10-K · filed 2014-02-14 |
| 2012-09-30 | $104.00M 10-Q · filed 2012-10-24 |
| 2011-12-31 | $120.00M 10-K · filed 2013-02-15 |
| 2010-12-31 | $147.00M 10-K · filed 2012-02-17 |
| 2009-12-31 | $180.00M 10-K · filed 2011-02-18 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |
| Zoetis Inc. (ZTS) | United States | $29.045B | 11.38 |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |